An announcement from Victrex ( (GB:VCT) ) is now available.
Victrex reported a solid start to FY 2025, with Q1 revenue up 9% and volume up 20% compared to the previous year. Despite this progress, trading conditions remain mixed, particularly in the Medical sector due to industry destocking. The company expects significant growth in its mega-programmes, such as Aerospace Composites and E-mobility, and anticipates improved cash flow and profitability supported by cost control and lower raw material costs. While full-year expectations remain unchanged, profit growth is expected to be more substantial in the second half of the year due to various factors, including currency impacts and costs from a new China facility.
More about Victrex
Victrex is an innovative leader in high-performance polymer solutions, focusing on strategic markets including Automotive, Aerospace, Energy & Industrial, Electronics, and Medical. With over 40 years of experience, the company produces sustainable materials for a wide range of applications, from smartphones and cars to medical devices, and is expanding into semi-finished and finished products.
YTD Price Performance: -3.63%
Average Trading Volume: 245,146
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £862.6M
For a thorough assessment of VCT stock, go to TipRanks’ Stock Analysis page.